US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.330
  • +0.130+2.10%
Close Feb 28 16:00 ET
  • 6.330
  • 0.0000.00%
Post 17:34 ET
562.08MMarket Cap-2.69P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.025M--
--2025/Q1-- / 4.460M--
--2024/Q413.080M / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 4.025M--
--2025/Q1-- / 4.460M--
--2024/Q413.080M / 4.238M--
--2024/Q36.865M / 3.256M--
Aug 8, 20242024/Q26.692M / 2.711M--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-K: FY2024 Annual Report

    Feb 27 07:46 ET

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

    Feb 27 07:15 ET

  • Verve Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 07:31 ET

  • Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

    Nov 5, 2024 07:16 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    LINTEX
    920106
    +30.00%
    LINGOOD
    833284
    +29.98%
    NTGEC
    870436
    +29.98%
    4
    CG MED EQUIP.
    838810
    +29.97%
    5
    Jiayu Holding
    300117
    +20.48%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.
    Discussing
    Tesla's earnings caused fluctuations, what's your market outlook？
    Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
    TSLA earnings preview: Grab rewards by guessing the opening price!